International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8002440
Original Article
Prevalence, Complications and Visual Outcome of Posterior Polar Cataract(PPC) among Patients Undergoing Surgery at A Tertiary Care Center
 ,
 ,
Published
June 4, 2023
Abstract
Purpose: To study the prevalence, complications and visual outcomes in patients with PPC undergoing small incision cataract surgery (SICS) Materials & Method: This is a prospective study of 96 patients undergoing surgery for PPC. All surgeries were performed by a single surgeon. All cases were bilateral and present in young age so the possibility of amblyopia was explained. They were also explained about preexisting posterior capsular dehiscence. After completion of continuous curvilinear capsulorhexis, controlled hydrodelineation was done in case of immature cataract. In the case of mature cataracts with PPC nucleus was separated from the capsule using spatula. Anterior vitrectomy done in case of posterior capsule rupture (PCR) & IOL placed in sulcus. Results: Total number of cataract surgery in one year was 6000. Prevalence of PPC was 1.6%. out of 96 cases overall rate of PCR was 10(10.41%). 3(3.1%) cases had cortical drop. 5(5.2%) cases showed cystoid macular edema (CME) as a complication which was treated with NSAID eye drop. All 96(100%) cases achieved a final visual acuity of 6/9 to 6/6 at 6 weeks follow up. Conclusion: clinical diagnosis and typing of cataract are most important in case of PPC. Before surgery patients should be counselled about the possibility of preexisting dehiscence, PCR occurring on table and the possible postoperative complications. During surgery care should be taken to avoid hydrodissection. Surgery done with due precautions gives good results in PPC.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
2950 Views
319 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved